Published, peer-reviewed research shows a patent-pending, virus-mimicking platform technology developed at Purdue University ...

People with color blindness may be less able to spot an early sign of bladder cancer, making them likelier to be diagnosed ...

Explore LENN nanoparticles, a groundbreaking technology for delivering mRNA therapies to bladder cancer cells with enhanced ...

A large U.S. health records study suggests that difficulty seeing blood in urine may put color-blind patients at higher risk.

On Jan. 20, 2026, investors weigh ImmunityBio’s sharp rally on new FDA feedback around its bladder cancer plans.

ImmunityBio, Inc. (NASDAQ: IBRX), a clinical-stage immunotherapy company, today announced that it recently held a Type B ...

ImmunityBio stock rose 19.8% after FDA meeting on ANKTIVA bladder cancer treatment. Company to submit additional data within ...

People who are colorblind may be missing a life-saving warning sign of bladder cancer. Analysis of the electronic health ...

What Is Zusduri Used For? Zusduri is used to treat a certain type of recurrent, persistent bladder cancer known as LG-IR-NMIBC. About 75% of people with bladder cancer present with non-muscle invasive ...

A retrospective cohort study suggested that people with color blindness may have a higher risk of mortality from bladder ...

Patients with color vision deficiency (CVD) with bladder cancer have shorter survival than those without CVD, accordi ...